Specific chemical inhibitors against four molecules linked with EMT—that is, Smad 2/3, ILK, AP-1, and SP-1—were added to ovarian cancer cells prior to their exposure to the malignant ascites to identify the signaling pathway(s) responsible for the induction of this process. The gene discussed is SP1; the disease is ovarian carcinoma.